ASP Isotopes (NASDAQ:ASPI) Director Michael Gorley Sells 30,000 Shares

ASP Isotopes Inc. (NASDAQ:ASPI) Director Michael Gorley sold 30,000 shares of the stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $6.27, for a total value of $188,100.00. Following the completion of the transaction, the director owned 87,908 shares in the company, valued at approximately $551,183.16. The trade was a 25.44% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.

ASP Isotopes Stock Down 0.8%

Shares of ASPI traded down $0.05 on Wednesday, reaching $6.17. The company’s stock had a trading volume of 3,923,284 shares, compared to its average volume of 4,990,399. ASP Isotopes Inc. has a twelve month low of $3.92 and a twelve month high of $14.49. The stock has a market capitalization of $776.80 million, a PE ratio of -2.97 and a beta of 3.51. The company has a current ratio of 4.39, a quick ratio of 4.37 and a debt-to-equity ratio of 0.69. The firm has a fifty day moving average of $6.24 and a 200-day moving average of $5.90.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings results on Wednesday, May 20th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.28) by $0.06. The business had revenue of $8.36 million during the quarter, compared to the consensus estimate of $3.68 million. ASP Isotopes had a negative return on equity of 112.46% and a negative net margin of 644.40%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of ASP Isotopes by 9.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company’s stock worth $148,000 after purchasing an additional 2,709 shares during the period. Rhumbline Advisers raised its position in ASP Isotopes by 20.9% in the second quarter. Rhumbline Advisers now owns 78,994 shares of the company’s stock worth $581,000 after acquiring an additional 13,668 shares during the period. XTX Topco Ltd bought a new stake in ASP Isotopes in the second quarter worth about $178,000. New York State Common Retirement Fund boosted its stake in ASP Isotopes by 418.2% in the second quarter. New York State Common Retirement Fund now owns 17,100 shares of the company’s stock valued at $126,000 after acquiring an additional 13,800 shares during the last quarter. Finally, Invesco Ltd. grew its position in shares of ASP Isotopes by 2,205.0% during the 2nd quarter. Invesco Ltd. now owns 471,219 shares of the company’s stock valued at $3,468,000 after acquiring an additional 450,776 shares during the period. Hedge funds and other institutional investors own 16.80% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on ASPI shares. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a research note on Wednesday, June 24th. Canaccord Genuity Group reissued a “buy” rating and set a $11.00 price target on shares of ASP Isotopes in a research report on Tuesday, April 14th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, ASP Isotopes has an average rating of “Hold” and an average price target of $13.00.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.